Table 3 Culture of drug-resistant bacteria in ocular secretions from patients with dacryocystitis, 2017 to 2022
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Χ2 | p value | |
|---|---|---|---|---|---|---|---|---|
(n = 961) | (n = 1307) | (n = 1220) | (n = 945) | (n = 838) | (n = 520) | |||
ESBLs, n(%) | 2(0.21) | 7(0.54) | 2(0.16) | 6(0.63) | 4(0.48) | 0(0) | 6.664 | 0.211 |
MRCNS, n(%) | 2(0.21) | 1(0.08) | 2(0.16) | 0(0) | 1(0.12) | 1(0.19) | 2.882 | 0.736 |
MRSA, n(%) | 8(0.83) | 14(1.07) | 12(0.98) | 13(1.38) | 19(2.27) | 15(2.88) | 17,688 | 0.003 |
CRE, n(%) | 0(0) | 1(0.08) | 0(0) | 2(0.21) | 1(0.12) | 0(0) | 4.006 | 0.415 |
CRPAE, n(%) | 0(0) | 1(0.08) | 1(0.08) | 3(0.32) | 0(0) | 1(0.19) | 5.071 | 0.246 |
β-lactamase positive, n(%) | 71(7.39) | 93(7.12) | 54(4.43) | 33(3.49) | 35(4.18) | 7(1.35) | 44.489 | 0.000 |